Beta Blocker News and Research

RSS
Beta-adrenergic receptor blocking agents (beta-blockers) are drugs with multiple actions on the heart. Blockade of beta-1 receptors results in slowing of heart rate, reduction in myocardial contractility, and lowering of systemic blood pressure. In the context of acute myocardial infarction (AMI), which represents a state of reduced oxygen supply to the affected portion of the heart, these effects may be beneficial as they result in reduced myocardial workload and oxygen demand. Furthermore, beta-blockers may reduce the risk of ventricular arrhythmias, which are an important cause of death following AMI.
New consensus-based recommendations designed to improve quality of life for DMD patients

New consensus-based recommendations designed to improve quality of life for DMD patients

Specific protein can be used as a brain marker to indicate whether emotional memories can be changed

Specific protein can be used as a brain marker to indicate whether emotional memories can be changed

AI approach helps identify heart failure patients who will benefit from beta-blocker therapy

AI approach helps identify heart failure patients who will benefit from beta-blocker therapy

Older heart failure patients less likely to receive recommended treatments

Older heart failure patients less likely to receive recommended treatments

Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients

Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients

Limiting the release of fat into the bloodstream during heart failure could help improve outcomes

Limiting the release of fat into the bloodstream during heart failure could help improve outcomes

Propranolol can be used to treat cerebral cavernous malformations

Propranolol can be used to treat cerebral cavernous malformations

Beta-blockers show anti-inflammatory effects in cirrhosis

Beta-blockers show anti-inflammatory effects in cirrhosis

Could beta-blockers be a potential treatment for COVID-19?

Could beta-blockers be a potential treatment for COVID-19?

Updated guideline on hypertrophic cardiomyopathy encourages shared decision-making

Updated guideline on hypertrophic cardiomyopathy encourages shared decision-making

Novel patient engagement tool improved outcomes for heart failure patients

Novel patient engagement tool improved outcomes for heart failure patients

Research reveals uncertainty in how to care for patients with certain type of heart attack

Research reveals uncertainty in how to care for patients with certain type of heart attack

Beta-blockers could be used to treat COVID-19, study finds

Beta-blockers could be used to treat COVID-19, study finds

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

Drug used to control blood pressure may improve cancer patients’ response to immunotherapy

Study shows unique cardioprotective properties of an old drug

Study shows unique cardioprotective properties of an old drug

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Study finds link between beta-blockers and survival outcomes in some breast cancer patients

Researchers analyze the effects of beta-blockers on men and women with hypertension

Researchers analyze the effects of beta-blockers on men and women with hypertension

Chilblains and COVID-19

Chilblains and COVID-19

Study provides molecular explanation to a longstanding mystery in viral oncology

Study provides molecular explanation to a longstanding mystery in viral oncology

Four drugs that could halt preterm labor identified

Four drugs that could halt preterm labor identified